Abstract
To define the association of the ingestion of nonsteroidal anti-inflammatory drugs (NSAIDs), including aspirin (ASA), and lower gastrointestinal bleeding (GIB) a retrospective, case-controlled study was undertaken of 188 patients admitted to three community hospitals in three cities with a diagnosis of lower GIB. Information was obtained about NSAID usage among these patients, and the data were compared with an age- and sex-matched control group of 185 patients admitted with a nongastrointestinal diagnosis, derived from a daily admission list. At the time of admission, in the New Jersey group, NSAID consumption was present in 26 of 90 (29%) patients with lower GIB compared with 16 of 90 (18%) of controls (P<0.05, odds ratio 1.88, 95% CI 1.2–3.1) whereas, in the South Carolina group 34 of 98 (35%) were taking NSAID compared with 18 of 95 (19%) of controls (P<0.01, odds ratio 2.27, 95% CI 1.2–4.4). These data indicate that there is a significantly increased rate of NSAID ingestion in patients admitted with lower GIB, implying that NSAID may unmask bleeding from a variety of lower gastrointestinal lesions.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Baragar FD, Duthie JJ: Importance of aspirin as a cause of anemia and peptic ulcer in rheumatoid arthritis. Br Med J 5179:1106–1108, 1960
Levy M: Aspirin use in patients with major upper gastrointestinal bleeding and peptic-ulcer disease. N Engl J Med 290:1158–1161, 1974
Armstrong CP, Blower AL: Non-steroidal anti-inflmmatory drugs and life threatening complications of peptic ulceration. Gut 28:527–532, 1987
Somerville K, Faulkner G, Langman M: Non-steroidal antiinflammatory drugs and bleeding peptic ulcer. Lancet 1:462–464, 1986
Abbas F, Trapp R, Lai G, Kolm P, Colliver J, Vasudeva R, Holt S: Sequential observations of symptoms and gastroduodenal damage due to non-steroidal anti-inflammatory drugs (NSAID). Am J Gastroenterology 83(9):1028, 1988
Holt S, Saleeby G: Gastric mucosal injury induced by nonsteroidal anti-inflammatory drugs. South Med J 84:355–360, 1991
Saleeby G, Holt S: Why do patients with life threatening complications of peptic ulce (PU) take non-steroidal antiinflammatory drugs (NSAID)? Am J Gastroenterol 85(9):1924, 1990
Saleeby G, Howden C, Holt S: Over the counter (OTC) non-steroidal anti-inflammatory drug (NSAID). Use may be an important determinant of complicated peptic ulcer disease (CPUD). Am J Gastroenterol 86(9):1375, 1991
Howden C, Holt S: Acid suppression as treatment for NSAID-related peptic ulcers. Am J Gastroenterol 86(12):1720–1721, 1991
Hall RI, Petty AH, Cobden I, Lendrum R: Enteritis and colitis associated with mefenamic acid. Br Med J 287:1182, 1983
Ravi S, Keat AC, Keat EC: Colitis caused by non-steroidal anti-inflammatory drugs. Postgrad Med J 62:773–776, 1986
Uribe A, Johansson C, Slezak P, Rubio C: Ulcerations of the colon associated with naproxen and acetylsalicylic acid treatment. Gastrointest Endosc 32:242–244, 1986
Varma J: Do nonsteroidal anti-inflammatory drugs cause lower gastrointestinal bleeding? A brief review. J Am Board Fam Pract 2:119–122, 1989
Langman MJS, Morgan L, Worral A: Use of anti-inflammatory drugs by patients admitted with small or large bowel perforations and haemorrhage. Br Med J 290:347–349, 1985
Kaufmann HJ, Taubin HL: Nonsteroidal anti-inflammatory drugs activate quiescent inflammatory bowel disease. Ann Intern Med 107(4):513–516, 1987
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Holt, S., Rigoglioso, V., Sidhu, M. et al. Nonsteroidal antiinflammatory drugs and lower gastrointestinal bleeding. Digest Dis Sci 38, 1619–1623 (1993). https://doi.org/10.1007/BF01303169
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01303169